Salma Alam

4.4k total citations
14 papers, 332 citations indexed

About

Salma Alam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Salma Alam has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Salma Alam's work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Salma Alam is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Salma Alam collaborates with scholars based in United Kingdom, United States and Germany. Salma Alam's co-authors include Robin L. Jones, David Olmos, Michelle Scurr, Ian Judson, Andrew Stephens, Srinivasu Poondru, Ana Sofia Martins, Scott M. Lippman, Faye M. Johnson and Pilar Nava-Parada and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Salma Alam

14 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salma Alam United Kingdom	10	160	143	91	86	66	14	332
Junichi Tomomatsu Japan	13	158 1.0×	232 1.6×	106 1.2×	38 0.4×	68 1.0×	49	431
Başak Oyan Türkiye	12	92 0.6×	155 1.1×	68 0.7×	32 0.4×	36 0.5×	39	348
Manali Bhave United States	10	115 0.7×	160 1.1×	67 0.7×	58 0.7×	29 0.4×	46	523
Christine Gennigens Belgium	13	98 0.6×	171 1.2×	146 1.6×	77 0.9×	54 0.8×	55	530
Isamu Hayashi Japan	12	212 1.3×	173 1.2×	112 1.2×	119 1.4×	36 0.5×	20	507
Pankhuri Wanjari United States	15	243 1.5×	65 0.5×	172 1.9×	70 0.8×	34 0.5×	35	467
Flavio Mavignier Cárcano Brazil	12	193 1.2×	89 0.6×	166 1.8×	101 1.2×	41 0.6×	34	418
Takehisa Hashimoto Japan	15	372 2.3×	230 1.6×	130 1.4×	70 0.8×	36 0.5×	42	647
Aurélie Ferru France	11	82 0.5×	250 1.7×	93 1.0×	86 1.0×	106 1.6×	30	439
Dominique Agbor‐Tarh Belgium	10	94 0.6×	362 2.5×	147 1.6×	129 1.5×	19 0.3×	22	516

Countries citing papers authored by Salma Alam

Since Specialization

Citations

This map shows the geographic impact of Salma Alam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma Alam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma Alam more than expected).

Fields of papers citing papers by Salma Alam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salma Alam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma Alam. The network helps show where Salma Alam may publish in the future.

Co-authorship network of co-authors of Salma Alam

This figure shows the co-authorship network connecting the top 25 collaborators of Salma Alam. A scholar is included among the top collaborators of Salma Alam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salma Alam. Salma Alam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Javed, Muhammad A., Georg Beyer, Alessio Vinci, et al.. (2018). Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. Pancreatology. 19(1). 97–104. 33 indexed citations

Alam, Salma, et al.. (2018). Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series. Case Reports in Oncology. 11(1). 221–227. 9 indexed citations

Noujaim, Jonathan, Salma Alam, Khin Thway, & Robin L. Jones. (2016). Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas. Indian Journal of Medical and Paediatric Oncology. 37(3). 125–130. 3 indexed citations

Alam, Salma, et al.. (2016). Association of ABO and Rh blood group systems with blood pressure in a population sample from Peshawar, NWFP, Pakistan. Annals of King Edward Medical University. 12(1). 1 indexed citations

Jones, Robin L., Edward S. Kim, Pilar Nava-Parada, et al.. (2014). Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors. Clinical Cancer Research. 21(4). 693–700. 77 indexed citations

Gounaris, Ioannis, et al.. (2014). Trabectedin for Advanced Soft Tissue Sarcomas: A Single Institution Experience. Future Oncology. 10(11). 1843–1851. 14 indexed citations

Martín-Liberal, Juan, Salma Alam, Anastasia Constantinidou, et al.. (2013). Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma. Sarcoma. 2013. 1–6. 50 indexed citations

Molife, L. Rhoda, Sarah Maria Rudman, Salma Alam, et al.. (2013). Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors. Cancer Chemotherapy and Pharmacology. 72(6). 1213–1222. 15 indexed citations

Molife, L. Rhoda, Salma Alam, David Olmos, et al.. (2012). Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience. Annals of Oncology. 23(8). 1968–1973. 16 indexed citations

10.

Alam, Salma, Charlotte Benson, David Olmos, et al.. (2012). Palliative ambulatory 14-day infusional ifosfamide in the outpatient setting for treatment of advanced soft tissue sarcomas (STS): “Old wine in a new bottle.”. Journal of Clinical Oncology. 30(15_suppl). 10039–10039. 1 indexed citations

11.

Zappala, Christopher, Sujal R. Desai, Susan J. Copley, et al.. (2011). Optimal scoring of serial change on chest radiography in sarcoidosis.. PubMed. 28(2). 130–8. 34 indexed citations

12.

Olmos, David, Ana Sofia Martins, Robin L. Jones, et al.. (2011). Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations. Sarcoma. 2011. 1–13. 49 indexed citations

13.

Carden, C. P., Robin L. Jones, Salma Alam, et al.. (2010). Phase I study of intermittent dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF- 1R) and insulin receptor (IR) in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). 2530–2530. 27 indexed citations

14.

Alam, Salma, David Olmos, Krunal Shah, et al.. (2010). Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: A single-center experience.. Journal of Clinical Oncology. 28(15_suppl). 2519–2519. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact